Analgesics in Nigeria

PROSPECTS

Arduous working conditions contribute to use of painkillers

Analgesics accounts for the largest share of drugs produced in Nigeria, due to their availability, widespread and affordability. Local drug manufacturing companies are largely involved in making over-the-counter (OTC) drugs because they have limited capacity to produce prescription medicines.

Strong growth shown by affordable and available acetaminophen

Acetaminophen has enjoyed strong growth despite accounting for the largest share of analgesics value sales over the review period. This is attributed to the fact that it can be combined with other drugs such as anti-malaria drugs to relieve headaches and pains.

Other analgesics expected to perform well

Diclofenac is another type of analgesic that is enjoying strong growth in Nigeria due to its strong action in relieving pain. Another type of analgesic expected to perform well is ibuprofen which, along with diclofenac, is a stronger pain killer than acetaminophen.

COMPETITIVE LANDSCAPE

Top three continue to dominate analgesics

Emzor Pharmaceutical Industries Ltd, May & Baker Nigeria Ltd and GlaxoSmithKline Consumer Nigeria Plc lead the category with their brands Emzor Paracetamol, M&B Paracetamol and Panadol, respectively. The first two brands are comparatively cheaper; Emzor Pharmaceutical Industries leads sales, particularly as a result of its strong retail distribution that is backed up by advertising at points of sale and sponsorship of the Super Eagles of Nigeria.

Files are delivered directly into your account within a few minutes of purchase.